Similar articles

• Sotalol reverses remodeled action potential in patients with chronic atrial fibrillation but does not prevent arrhythmia recurrence.

  Osaka T, Yamazaki M, Yokoyama E, Ito A, Kodama I. Osaka T, et al. J Cardiovasc Electrophysiol. 2004 Aug;15(8):877-84. doi: 10.1046/j.1540-8167.2004.03671.x. J Cardiovasc Electrophysiol. 2004. PMID: 15333078 Clinical Trial.
• Effects of amiodarone on electrical and structural remodeling induced in a canine rapid pacing-induced persistent atrial fibrillation model.

  Ashikaga K, Kobayashi T, Kimura M, Owada S, Sasaki S, Iwasa A, Furukawa K, Motomura S, Okumura K. Ashikaga K, et al. Eur J Pharmacol. 2006 Apr 24;536(1-2):148-53. doi: 10.1016/j.ejphar.2006.02.023. Epub 2006 Mar 6. Eur J Pharmacol. 2006. PMID: 16556442
• Reversal of remodeling in atrial fibrillation: a positive double-negative?

  George Wyse D. George Wyse D. J Cardiovasc Electrophysiol. 2004 May;15(5):513-4. doi: 10.1046/j.1540-8167.2004.03674.x. J Cardiovasc Electrophysiol. 2004. PMID: 15149417 No abstract available.
• Post-cardioversion atrial fibrillation: the synthesis of modern concepts?

  Peters NS. Peters NS. Eur Heart J. 2000 Jul;21(14):1119-21. doi: 10.1053/euhj.2000.2143. Eur Heart J. 2000. PMID: 10924292 Review. No abstract available.
• Factors in the genesis of atrial fibrillation in rheumatic valvular disease.

  Noble RJ, Fisch C. Noble RJ, et al. Cardiovasc Clin. 1973;5(2):97-114. Cardiovasc Clin. 1973. PMID: 4130954 Review. No abstract available.